Document Detail

Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.
MedLine Citation:
PMID:  19620509     Owner:  NLM     Status:  MEDLINE    
Production and clearance of plasma C-type natriuretic peptide (CNP) and amino terminal (NT)-proCNP immunoreactivity in the human circulation remain poorly characterized. Accordingly, we have measured arterial and venous concentrations of CNP and NT-proCNP across multiple tissue beds during cardiac catheterization in 120 subjects (age: 64.2+/-9.0 years; 73% men) investigated for cardiovascular disorders. The heart, head and neck, and musculoskeletal tissues made the clearest contributions to both plasma CNP and NT-proCNP (P<0.05). Net release of NT-proCNP was also observed from hepatic tissue (P<0.001). Negative arteriovenous gradients for CNP were observed across renal, hepatic, and pulmonary tissue (P<0.05), indicating net clearance, whereas no tissue-specific site of NT-proCNP clearance was identified. Age, mean pulmonary artery pressure, left ventricular end diastolic pressure, Brandt score of myocardial jeopardy, and troponin I were independent predictors of circulating CNP levels in multivariable analysis. Sex and kidney function were independently predictive of arterial NT-proCNP. The proportional step-up of CNP (+60%) across the heart was less than for brain natriuretic peptide (+123%) but greater than for NT-pro-brain natriuretic peptide (NT-proBNP) (+36%) and NT-proCNP (+42%; P<0.001 for all). We conclude that cardiac and head and neck tissue are important sources of CNP. Circulating CNP but not NT-proCNP concentrations are related to cardiac hemodynamic load and ischemic burden. Although cardiac release is most evident, multiple additional tissues release NT-proCNP immunoreactivity without evidence for an organ-specific site for NT-proCNP degradation. Taken together, differences in magnitude and direction of transorgan gradients for CNP compared with NT-proCNP suggest net generalized cosecretion with differing mechanisms of clearance.
Suetonia C Palmer; Timothy C R Prickett; Eric A Espiner; Timothy G Yandle; A Mark Richards
Related Documents :
20802109 - Catecholamines, cardiac natriuretic peptides and chromogranin a: evolution and physiopa...
16172169 - Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion ...
16843549 - The significance of 123i-bmipp delayed scintigraphic imaging in cardiac patients.
19942089 - Soluble st2 for predicting sudden cardiac death in patients with chronic heart failure ...
14667259 - Cardiac troponin levels in heart failure.
19466519 - Efficacy and safety of carvedilol for heart failure in children and patients with conge...
11052189 - Mechanical support for postcardiotomy cardiogenic shock.
24414329 - Left ventricular aneurysm/reshaping techniques.
15061869 - A single-nucleotide polymorphism in the human p27kip1 gene (-838c>a) affects basal prom...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-07-20
Journal Detail:
Title:  Hypertension     Volume:  54     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-20     Completed Date:  2009-09-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  612-8     Citation Subset:  IM    
Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / blood,  physiopathology*
Middle Aged
Multivariate Analysis
Natriuretic Peptide, Brain / blood
Natriuretic Peptide, C-Type / blood*,  chemistry
Peptide Fragments / blood*
Protein Precursors / blood,  chemistry
Reg. No./Substance:
0/Peptide Fragments; 0/Protein Precursors; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain; 127869-51-6/Natriuretic Peptide, C-Type

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.
Next Document:  Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity i...